Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Return on Sales (2024 - 2025)

Incannex Healthcare's Return on Sales history spans 2 years, with the latest figure at 1304.2% for Q4 2025.

  • For Q4 2025, Return on Sales fell 81312.0% year-over-year to 1304.2%; the TTM value through Dec 2025 reached 4850.0%, down 457355.0%, while the annual FY2025 figure was 545.17%, 99308.0% up from the prior year.
  • Return on Sales for Q4 2025 was 1304.2% at Incannex Healthcare, down from 1281.4% in the prior quarter.
  • Across five years, Return on Sales topped out at 73.24% in Q3 2024 and bottomed at 1304.2% in Q4 2025.